Can Sorafenib be reimbursed? How much does it cost under medical insurance?

The original drug Sorafenib (Sorafenib) has been launched in China and has entered the scope of medical insurance. Different regions have different reimbursement ratios, and the price after reimbursement may vary. The price of 0.2g*60 tablets may be around RMB 1,200. The original drug of sorafenib has also been launched overseas, and there are also generic drugs of sorafenib produced in other countries. The price of 0.2g*60 tablets produced by a Bangladesh pharmaceutical factory is around RMB 450 (the price may fluctuate due to the exchange rate). The ingredients of the original drug are basically the same as those of the generic drugs.

Sorafenib is used to treat advanced kidney cancer(advanced renal cell carcinoma), liver cancer that cannot be treated with surgery (hepatocellular carcinoma), and differentiated thyroid cancer that has come back or spread to other parts of the body. Sorafenib is an antineoplastic (cancer) drug. Sorafenib can reduce the invasion and metastasis ability of tumor cells and reduce the risk of distant metastasis. It interferes with the growth of cancer cells and is eventually destroyed by the body. This medicine is only available with a doctor's prescription.

Sorafenib has been shown to significantly prolong survival in patients with malignant tumors such as renal cell carcinoma, hepatocellular carcinoma, and thyroid cancer. It can reduce the risk of tumor recurrence and improve overall patient survival. Sorafenib may cause some side effects, including hand-foot syndrome, high blood pressure, diarrhea, rash, etc. Therefore, before a patient uses sorafenib, the doctor will evaluate the patient's overall health condition and drug tolerance and formulate an individualized treatment plan. When patients decide to use a drug, they must weigh the risks and benefits of taking the drug.